Skip to main content

Table 1 Clinical and demographic features of patients with non-131I-avid and 131I-avid lungs metastases

From: miRNA-106a directly targeting RARB associates with the expression of Na+/I symporter in thyroid cancer by regulating MAPK signaling pathway

Clinical Characteristics

Groups

P value

non-131I-avid (N = 47)

131I-avid (N = 72)

Age/years

  

0.55

 Median (range)

43 (28–60)

42 (27–55)

 

Gender

  

0.90

 Male (%)

21 (44.7)

33 (45.8)

 

 Female (%)

26 (55.3)

39 (54.2)

 

Tg level (ng/ml)

  

0.77

 Median (range)

1213.5 (304.7–3121.9)

1324.3 (324.9–3249.5)

 

TgAb level (IU/ml)

  

0.72

 Median (range)

45.6 (10–125.6)

43.8 (10–150.3)

 

Histological diagnosis

PTC

PTC

Primary tumor

  

T stage

  

 T1

17

27

 T2

19

30

 T3

9

12

 T4

2

3

N stage

  

 N0

0

0

 N1

46

70

 Nx

1

2

Chest CT scan

Diffuse small nodules

Diffuse small nodules

131I up take in lungs

Close to upper limbs

Diffuse lung uptake

Extent of disease

No other metastasis

No other metastasis

Other cancer history

No

No

Other treatment

No

No